{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:28:07Z","timestamp":1756463287006},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12149-020-01464-9","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T14:02:36Z","timestamp":1587045756000},"page":"415-423","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index"],"prefix":"10.1007","volume":"34","author":[{"given":"Fumi","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Tomiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"1464_CR1","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 2009;8:1150\u20137.","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"1464_CR2","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.parkreldis.2015.09.034","volume":"22","author":"D Aarsland","year":"2016","unstructured":"Aarsland D. Cognitive impairment in Parkinson's disease and dementia with Lewy bodies. Parkinsonism Relat Disord. 2016;22(Suppl 1):S144\u2013148.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"1464_CR3","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10072-017-2936-3","volume":"38","author":"J Ueda","year":"2017","unstructured":"Ueda J, Yoshimura H, Shimizu K, Hino M, Kohara N. Combined visual and semi-quantitative assessment of 123I-FP-CIT SPECT for the diagnosis of dopaminergic neurodegenerative diseases. Neurol Sci. 2017;38(7):1187\u201391. https:\/\/doi.org\/10.1007\/s10072-017-2936-3.","journal-title":"Neurol Sci"},{"key":"1464_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;67:189\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1464_CR5","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology. 1999;53:1020\u20135.","journal-title":"Neurology"},{"issue":"5","key":"1464_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s002590050544","volume":"27","author":"Junichi Taki","year":"2000","unstructured":"Taki J, Nakajima K, Hwang EH, et al. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp. European journal of nuclear medicine 2000; 27:566\u2013573","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"1464_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2967\/jnumed.111.100784","volume":"53","author":"DS Djang","year":"2012","unstructured":"Djang DS, Janssen MJ, Bohnen N, et al. SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med. 2012;53:154\u201363.","journal-title":"J Nucl Med"},{"key":"1464_CR8","first-page":"1785","volume":"27","author":"M Nakajo","year":"1986","unstructured":"Nakajo M, Taguchi M, Shimabukuro K, Shinohara S. Iodine-131 MIBG uptake in a small cell carcinoma of the lung. J Nucl Med. 1986;27:1785\u20136.","journal-title":"J Nucl Med"},{"key":"1464_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0300-2977(94)00098-0","volume":"46","author":"L Apeldoorn","year":"1995","unstructured":"Apeldoorn L, Voerman HJ, Hoefnagel CA. Interference of MIBG uptake by medication: a case report. Neth J Med. 1995;46:239\u201343.","journal-title":"Neth J Med"},{"key":"1464_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/jnnp.74.3.294","volume":"74","author":"A Winogrodzka","year":"2003","unstructured":"Winogrodzka A, Bergmans P, Booij J, van Royen EA, Stoof JC, Wolters EC. [(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease. J Neurol Neurosurg Psychiatry. 2003;74:294\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1464_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00259-015-3146-y","volume":"43","author":"S Shimizu","year":"2016","unstructured":"Shimizu S, Hirao K, Kanetaka H, et al. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2016;43:184\u201392.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1464_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00702-004-0208-x","volume":"112","author":"M Plotkin","year":"2005","unstructured":"Plotkin M, Amthauer H, Klaffke S, et al. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm (Vienna). 2005;112:677\u201392.","journal-title":"J Neural Transm (Vienna)"},{"key":"1464_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/MNM.0000000000000674","volume":"38","author":"N Uyama","year":"2017","unstructured":"Uyama N, Otsuka H, Shinya T, et al. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes. Nucl Med Commun. 2017;38:487\u201392.","journal-title":"Nucl Med Commun"},{"key":"1464_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","volume":"76","author":"H Nagayama","year":"2005","unstructured":"Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2005;76:249\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1464_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00702-006-0518-2","volume":"114","author":"J Spiegel","year":"2007","unstructured":"Spiegel J, Hellwig D, Samnick S, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease. J Neural Transm (Vienna). 2007;114:331\u20135.","journal-title":"J Neural Transm (Vienna)"},{"key":"1464_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/mds.20369","volume":"20","author":"J Spiegel","year":"2005","unstructured":"Spiegel J, Mollers MO, Jost WH, et al. FP-CIT and MIBG scintigraphy in early Parkinson's disease. Mov Disord. 2005;20:552\u201361.","journal-title":"Mov Disord"},{"key":"1464_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2967\/jnumed.110.086959","volume":"52","author":"M Sudmeyer","year":"2011","unstructured":"Sudmeyer M, Antke C, Zizek T, et al. Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach. J Nucl Med. 2011;52:733\u201340.","journal-title":"J Nucl Med"},{"key":"1464_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00259-009-1267-x","volume":"37","author":"J Darcourt","year":"2010","unstructured":"Darcourt J, Booij J, Tatsch K, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1464_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00259-011-1963-1","volume":"39","author":"K Nakajima","year":"2012","unstructured":"Nakajima K, Okuda K, Matsuo S, et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging. 2012;39:113\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1464_CR20","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s12350-014-9916-2","volume":"21","author":"K Nakajima","year":"2014","unstructured":"Nakajima K, Okuda K, Yoshimura M, et al. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol. 2014;21:970\u20138.","journal-title":"J Nucl Cardiol"},{"key":"1464_CR21","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","volume":"33","author":"L Tossici-Bolt","year":"2006","unstructured":"Tossici-Bolt L, Hoffmann SM, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging. 2006;33:1491\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1464_CR22","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00259-018-3976-5","volume":"45","author":"H Matsuda","year":"2018","unstructured":"Matsuda H, Murata M, Mukai Y, et al. Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging. 2018;45:1405\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1464_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00259-015-3146-y","volume":"43","author":"S Shimizu","year":"2015","unstructured":"Shimizu S, Hirao K, Kanetaka H, et al. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2015;43(1):184\u201392.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1464_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"issue":"Suppl 7","key":"1464_CR25","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1002\/mds.10574","volume":"18","author":"V Marshall","year":"2003","unstructured":"Marshall V, Grosset DG. Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders. Mov Disord. 2003;18(Suppl 7):S22\u201327.","journal-title":"Mov Disord"},{"key":"1464_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2377-7-27","volume":"7","author":"AM Vlaar","year":"2007","unstructured":"Vlaar AM, van Kroonenburgh MJ, Kessels AG, Weber WE. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol. 2007;7:27.","journal-title":"BMC Neurol"},{"key":"1464_CR27","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s00415-019-09202-6","volume":"266","author":"E Makinen","year":"2019","unstructured":"Makinen E, Joutsa J, Jaakkola E, et al. Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT. J Neurol. 2019;266:826\u201334.","journal-title":"J Neurol"},{"key":"1464_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12149-017-1166-3","volume":"31","author":"S Shimizu","year":"2017","unstructured":"Shimizu S, Hirose D, Namioka N, et al. Correlation between clinical symptoms and striatal DAT uptake in patients with DLB. Ann Nucl Med. 2017;31:390\u20138.","journal-title":"Ann Nucl Med"},{"key":"1464_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith I, O'Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305\u201313.","journal-title":"Lancet Neurol"},{"key":"1464_CR30","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/mds.21685","volume":"22","author":"SA Schneider","year":"2007","unstructured":"Schneider SA, Edwards MJ, Mir P, et al. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord. 2007;22:2210\u20135.","journal-title":"Mov Disord"},{"key":"1464_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jnnp-2014-310256","volume":"87","author":"R Erro","year":"2016","unstructured":"Erro R, Schneider SA, Stamelou M, Quinn NP, Bhatia KP. What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies. J Neurol Neurosurg Psychiatry. 2016;87:319\u201323.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1464_CR32","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s00259-016-3312-x","volume":"43","author":"JJ van der Zande","year":"2016","unstructured":"van der Zande JJ, Booij J, Scheltens P, Raijmakers PG, Lemstra AW. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies. Eur J Nucl Med Mol Imaging. 2016;43:1060\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1464_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain J Neurol. 2008;131:642\u201350.","journal-title":"Brain J Neurol"},{"key":"1464_CR34","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1212\/WNL.57.6.1140","volume":"57","author":"S Orimo","year":"2001","unstructured":"Orimo S, Ozawa E, Oka T, et al. Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology. 2001;57:1140\u20131.","journal-title":"Neurology"},{"key":"1464_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14802\/jmd.15015","volume":"8","author":"EJ Chung","year":"2015","unstructured":"Chung EJ, Kim SJ. (123)I-Metaiodobenzylguanidine myocardial scintigraphy in Lewy body-related disorders: a literature review. J Mov Disord. 2015;8:55\u201366.","journal-title":"J Mov Disord"},{"key":"1464_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2169\/internalmedicine.42.127","volume":"42","author":"S Orimo","year":"2003","unstructured":"Orimo S, Ozawa E, Nakade S, et al. [123I] meta-iodobenzylguanidine myocardial scintigraphy differentiates corticobasal degeneration from Parkinson's disease. Intern Med. 2003;42:127\u20138.","journal-title":"Intern Med"},{"key":"1464_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1552-6569.2010.00532.x","volume":"22","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cason E. Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis. J Neuroimaging. 2012;22:111\u20137.","journal-title":"J Neuroimaging"},{"key":"1464_CR38","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.parkreldis.2012.04.017","volume":"18","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cason E. Meta-analysis on MIBG scintigraphy in differential diagnosis between Parkinson's disease and neurodegenerative parkinsonism. Parkinsonism Relat Disord. 2012;18:805 (author reply 806).","journal-title":"Parkinsonism Relat Disord"},{"key":"1464_CR39","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1093\/brain\/aws211","volume":"135","author":"SJ Colloby","year":"2012","unstructured":"Colloby SJ, McParland S, O'Brien JT, Attems J. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain J Neurol. 2012;135:2798\u2013808.","journal-title":"Brain J Neurol"},{"key":"1464_CR40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13139-016-0394-0","volume":"50","author":"A Van Der Gucht","year":"2016","unstructured":"Van Der Gucht A, de Langavant CL, Belissant O, et al. Brain (18)F-FDG, (18)F-Florbetaben PET\/CT, (123)I-FP-CIT SPECT and Cardiac (123)I-MIBG imaging for diagnosis of a \"cerebral type\" of Lewy body disease. Nucl Med Mol Imaging. 2016;50:258\u201360.","journal-title":"Nucl Med Mol Imaging"},{"key":"1464_CR41","first-page":"476","volume":"55","author":"V Camacho","year":"2011","unstructured":"Camacho V, Marquie M, Lleo A, et al. Cardiac sympathetic impairment parallels nigrostriatal degeneration in probable dementia with Lewy bodies. Q J Nucl Med Mol Imaging. 2011;55:476\u201383.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1464_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1552-6569.2012.00774.x","volume":"24","author":"G Treglia","year":"2014","unstructured":"Treglia G, Cason E, Cortelli P, et al. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? J Neuroimaging. 2014;24:149\u201354.","journal-title":"J Neuroimaging"},{"key":"1464_CR43","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/mds.22771","volume":"24","author":"F Novellino","year":"2009","unstructured":"Novellino F, Arabia G, Bagnato A, et al. Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors. Mov Disord. 2009;24:2242\u20138.","journal-title":"Mov Disord"},{"key":"1464_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1017\/S0317167100012920","volume":"40","author":"JS Kim","year":"2013","unstructured":"Kim JS, Youn J, Shin H, Cho JW. Nonmotor symptoms in drug-induced parkinsonism and drug-naive Parkinson disease. Can J Neurol Sci. 2013;40:36\u201341.","journal-title":"Can J Neurol Sci"},{"key":"1464_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00259-009-1202-1","volume":"37","author":"K Ishibashi","year":"2010","unstructured":"Ishibashi K, Saito Y, Murayama S, et al. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET. Eur J Nucl Med Mol Imaging. 2010;37:3\u201311.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1464_CR46","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10072-012-1244-1","volume":"34","author":"W Jang","year":"2013","unstructured":"Jang W, Kim JS, Cho JW, et al. Cardiac sympathetic denervation in Parkinson's disease patients with SWEDDs. Neurol Sci. 2013;34:1375\u201382.","journal-title":"Neurol Sci"},{"key":"1464_CR47","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s12149-013-0702-z","volume":"27","author":"A Chiaravalloti","year":"2013","unstructured":"Chiaravalloti A, Stefani A, Di Biagio D, et al. Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease. Ann Nucl Med. 2013;27:444\u201351.","journal-title":"Ann Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01464-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-020-01464-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01464-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T01:36:23Z","timestamp":1618536983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-020-01464-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1464"],"URL":"https:\/\/doi.org\/10.1007\/s12149-020-01464-9","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"27 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest or financial disclosure relevant to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board approval was obtained. Study subjects or cohorts overlap: no cohorts have been previously reported in our study. These findings have not been presented at any meetings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}